ABCC9 and Alzheimer disease: The majority (76%) of these randomly selected DEGs in 3xTg-AD mice (Figure 1A, Table 2) did not appear as DEGs following CBD treatment (Figure 1C, Supplementary Table 6), noting absence of some select markers for neurological aging (e.g., Abcc9 and Postn), hypercholesterolemia (e.g., Acat3), and inflammation (e.g., Alox8).